Your browser is no longer supported. Please, upgrade your browser.
BPTH Bio-Path Holdings, Inc. daily Stock Chart
Bio-Path Holdings, Inc.
Index- P/E- EPS (ttm)-3.00 Insider Own1.02% Shs Outstand4.54M Perf Week4.82%
Market Cap14.41M Forward P/E- EPS next Y-2.20 Insider Trans0.00% Shs Float4.50M Perf Month-6.45%
Income-10.70M PEG- EPS next Q-0.78 Inst Own7.80% Short Float2.61% Perf Quarter-19.44%
Sales- P/S- EPS this Y77.50% Inst Trans-7.19% Short Ratio0.12 Perf Half Y-37.07%
Book/sh3.57 P/B0.97 EPS next Y27.60% ROA-57.30% Target Price- Perf Year-50.07%
Cash/sh2.92 P/C1.19 EPS next 5Y- ROE-62.90% 52W Range2.92 - 8.65 Perf YTD-56.45%
Dividend- P/FCF- EPS past 5Y20.40% ROI- 52W High-59.76% Beta2.09
Dividend %- Quick Ratio10.00 Sales past 5Y- Gross Margin- 52W Low19.17% ATR0.30
Employees9 Current Ratio10.00 Sales Q/Q- Oper. Margin- RSI (14)46.37 Volatility6.60% 6.87%
OptionableNo Debt/Eq0.00 EPS Q/Q-3.00% Profit Margin- Rel Volume0.10 Prev Close3.47
ShortableYes LT Debt/Eq0.00 EarningsNov 13 BMO Payout- Avg Volume941.94K Price3.48
Recom- SMA203.05% SMA50-10.60% SMA200-26.39% Volume92,446 Change0.29%
Nov-13-17Reiterated H.C. Wainwright Buy $4.50 → $1.50
Aug-10-16Reiterated Maxim Group Buy $5 → $2
Apr-18-16Initiated Rodman & Renshaw Buy $5
Jun-02-14Resumed Maxim Group Buy $5
May-09-14Initiated Maxim Group Buy $5
Nov-19-20 07:00AM  
Nov-13-20 07:00AM  
Nov-06-20 08:00AM  
Oct-22-20 07:00AM  
Sep-18-20 12:00PM  
Sep-09-20 08:00AM  
Aug-14-20 07:00AM  
Aug-13-20 07:00AM  
Aug-07-20 08:00AM  
Jun-25-20 11:28PM  
Jun-17-20 07:30AM  
May-29-20 08:00AM  
May-15-20 07:00AM  
May-13-20 05:00PM  
May-08-20 08:00AM  
Apr-27-20 09:00AM  
Apr-13-20 07:00AM  
Mar-13-20 07:39PM  
Mar-11-20 07:00AM  
Mar-06-20 07:00AM  
Feb-28-20 08:00AM  
Feb-21-20 10:34AM  
Jan-23-20 09:07AM  
Jan-08-20 08:00AM  
Dec-06-19 09:25AM  
Dec-05-19 09:42PM  
Dec-04-19 12:00PM  
Nov-26-19 08:00AM  
Nov-25-19 02:11PM  
Nov-21-19 11:30AM  
Nov-15-19 07:00AM  
Nov-08-19 08:00AM  
Oct-29-19 06:47AM  
Oct-16-19 02:29PM  
Oct-15-19 08:00AM  
Sep-25-19 08:00AM  
Sep-14-19 09:36AM  
Sep-04-19 01:10AM  
Sep-03-19 04:01PM  
Aug-26-19 07:00AM  
Aug-15-19 07:00AM  
Aug-08-19 04:01PM  
Jul-17-19 11:39AM  
Jul-16-19 08:18AM  
Jun-04-19 11:51AM  
May-16-19 07:05AM  
May-15-19 08:16AM  
May-10-19 04:01PM  
Apr-29-19 09:00AM  
Apr-15-19 04:33PM  
Apr-03-19 08:00AM  
Mar-21-19 06:13AM  
Mar-20-19 09:15AM  
Mar-15-19 04:01PM  
Mar-14-19 03:10PM  
Mar-12-19 09:15AM  
Mar-08-19 01:25PM  
Mar-07-19 11:55AM  
Mar-06-19 02:35PM  
Mar-04-19 06:10AM  
Feb-28-19 08:00AM  
Jan-24-19 04:30PM  
Jan-23-19 04:01PM  
Jan-18-19 12:31PM  
Jan-17-19 04:07PM  
Jan-16-19 08:24AM  
Jan-14-19 10:23PM  
Dec-27-18 08:49AM  
Dec-26-18 09:47AM  
Dec-03-18 07:22AM  
Nov-25-18 09:41AM  
Nov-15-18 07:20AM  
Nov-08-18 04:01PM  
Nov-01-18 09:05AM  
Oct-09-18 01:11PM  
Sep-25-18 04:01PM  
Sep-21-18 06:30AM  
Aug-29-18 08:00AM  
Aug-27-18 07:30AM  
Aug-16-18 10:26AM  
Aug-15-18 07:05AM  
Aug-08-18 09:15AM  
Jun-26-18 08:00AM  
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome; and in Phase IIa clinical trials for the treatment of chronic myeloid leukemia, as well as to treat solid tumors. The company is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.